Vitamina D y trasplante hepático, ¿sólo efectos óseos?

  1. Sonsoles Guadalix Iglesias 1
  2. Elena García Fernández 1
  3. Helena Requejo Salinas 1
  4. María Calatayud Gutiérrez 1
  5. Esteban Jódar Gimeno 1
  1. 1 Hospital Universitario 12 de Octubre
    info

    Hospital Universitario 12 de Octubre

    Madrid, España

    ROR https://ror.org/00qyh5r35

Journal:
Revista Española de Enfermedades Metabólicas Oseas

ISSN: 1132-8460

Year of publication: 2006

Volume: 15

Issue: 1

Pages: 13-17

Type: Article

DOI: 10.1016/S1132-8460(06)75252-7 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Española de Enfermedades Metabólicas Oseas

Abstract

Liver transplantation has become a fairly common and successful procedure, and post-transplantation osteoporosis is now a usual complication in these patients. Immuno-suppressive therapy has been involved in this setting. Vitamin D and their related analogs may have a role in the post-transplantation therapy, adding the role of immuno-modulator (mainly in T cells) to their already protective one in bone metabolism. This might not only allow for the possibility of reducing immuno-suppressive doses, but also of reducing instances of transplant rejections.

Data source: Dialnet